PP-001 Chemotherapeutic implications of peptide deformylase against experimental tuberculosis  by Sharma, A. et al.
International Journal of Infectious Diseases (2008) 12(S3) S55–S81
Poster Presentations
Poster Presentation Tuberculosis
PP-001 Chemotherapeutic implications of peptide
deformylase against experimental tuberculosis
A. Sharma, S. Sharma*, G.K. Khuller. Department of
Biochemistry, Post Graduate Institute of Medical Education
and Research, Chandigarh-160012, India
Objectives: The present study explores the potential of
known peptide deformylase (PDF) inhibitors as chemother-
apeutic agents against experimental tuberculosis.
Methods: Several PDF inhibitors like BB-3497, actinonin,
1, 10-phenanthroline, hydroxylamine hydrochloride, and
galardin that have shown their potential against other
bacteria were selected for their evaluation against
Mycobacterium tuberculosis.
Results: Based on in vitro studies, the minimum inhibitory
concentration (MIC) of PDF inhibitors was found to be
in the range of 0.2 74mg/L, and among different PDF
inhibitors, BB-3497 and 1, 10-phenanthroline exhibited
potent antimycobacterial activity. In addition PDF inhibitors
exhibited bacteriostatic mode of inhibition. Ex vivo studies
with BB-3497 and actinonin led to reduction of colony
forming units (cfu) by almost 2 log10 units at their
MIC concentration. Moreover, reduction of cfu by BB-
3497 was comparable to that of isoniazid. Under short
course chemotherapy, BB-3497 was signiﬁcantly active and
comparable to isoniazid. Extended chemotherapy of 6 weeks
with BB-3497 and actinonin revealed BB-3497 to be more
potent under in vivo condition. Interestingly, BB-3497 and
actinonin exhibited synergism with isoniazid and rifampicin
under in vitro conditions and during chemotherapy of
murine tuberculosis.
Conclusions: Peptide deformylase inhibitors like BB-3497
and actinonin showed their efﬁcacy against Mycobacterium
tuberculosis under in vitro, ex vivo and in vivo conditions
and BB-3497 was found to be the most efﬁcacious
inhibitor. Thus PDF from M. tuberculosis appears to be an
attractive target for development of new antibiotics against
tuberculosis.
PP-002 Comparison of prevalence of pulmonary
tuberculosis among diabetics and non diabetics
patients in primary care centre
A. Shahzad*. Ch-KD&RL Bhakker, Pakistan
Objective: The aim of present study was to see the
Comparison of Prevalence of Pulmonary Tuberculosis among
known diabetic and non diabetics outdoor patients in
primary care centre.
Design: An observational study conducted on known diabetic
and non diabetic outdoor patients.
Place and Duration of Study: The study was conducted in
primary care centre at Ch-KD&RL Bhakker, Pakistan from
Feb 2007 Sept 2007.
Patients and Methods: One hundred and ﬁfty known
diabetic outdoor patients were screened for pulmonary
tuberculosis and compared with 150 non diabetic controls
seen consecutively during the same period.
Results: The study showed the prevalence of pulmonary
tuberculosis among diabetic patients was 10% compared to
non-diabetic patients who had prevalence of 3% (P-Value
<0.001) which showed 8% higher risk in diabetic patients.
Conclusion: It was concluded that problem of pulmonary
tuberculosis is signiﬁcant in diabetic patients as compared
to non diabetic patients. The results suggest that we should
screen diabetic patients with respiratory complaints for
pulmonary tuberculosis at primary care centre and start
early anti tuberculosis treatment.
PP-003 Evaluation on the cellular immunity of M.
tuberculosis in HIV/AIDS and tuberculosis
co-infected individuals in China
S. Zhang1 *, L.Y. Shao1, C.Y. Meng1, Ying Wang1, L.L. Huang1,
Yun Wang1, X.H. Weng1, W.H. Zhang1, Y.Y. Xu2, H.Y. Hu2.
1Department of Infectious Diseases, Huashan Hospital,
Fudan University, Shanghai, China, 2Department of
Infectious Diseases, No. 1 People Hospital, Honghe State,
Yunnan, China
Objective: To investigate the prevalence of latent
tuberculosis co-infection in HIV/AIDS population and
evaluate the cellular immunity of M. tuberculosis (MTB)
in latent tuberculosis or active tuberculosis and HIV/AIDS
co-infected individuals in China.
Methods: The ELISPOT assay (T SPOT-TB assay) induced by
speciﬁc peptide antigens, ESAT-6 and CFP-10, was employed
to detect MTB speciﬁc T cells in blood samples from 100 HIV-
positive individuals in Yunnan Province. Flow cytometry was
performed on all the participants to detect absolute CD4+
and CD8+ T cell counts.
Results: The prevalence of latent tuberculosis co-infection
in HIV-positive individuals without any clinical evidence of
active tuberculosis was 67.65% in China. The CD4+ and
CD8+ T cell counts in HIV-positive individuals with latent
tuberculosis co-infection were similar to those in patients
who had HIV infection only, while those cell counts in HIV-
positive individuals with active tuberculosis co-infection
were dramatically decreased (P < 0.01). The ESAT-6 and
CFP-10 speciﬁc spot-forming cells in HIV-positive individuals
with active tuberculosis co-infection were signiﬁcantly
less than those in HIV-positive individuals with latent
tuberculosis co-infection (P < 0.01).
Conclusion: In China, there was a high prevalence of
latent tuberculosis co-infection in HIV-positive individuals
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